PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 93 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $9,140,000 | +34.6% | 2,268,000 | +44.3% | 0.53% | +17.1% |
| Q3 2019 | $6,791,000 | -31.3% | 1,572,000 | -36.6% | 0.45% | -27.8% |
| Q2 2019 | $9,887,000 | -13.2% | 2,478,000 | +16.7% | 0.62% | 0.0% |
| Q1 2019 | $11,385,000 | +12.8% | 2,124,000 | +7.9% | 0.62% | -18.6% |
| Q4 2018 | $10,096,000 | -13.3% | 1,968,000 | +64.0% | 0.76% | +9.4% |
| Q3 2018 | $11,640,000 | +0.8% | 1,200,000 | +6.0% | 0.70% | -7.3% |
| Q2 2018 | $11,546,000 | +53.1% | 1,132,000 | +95.2% | 0.75% | +30.7% |
| Q1 2018 | $7,540,000 | – | 580,000 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
| Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
| Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
| Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
| Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
| Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
| HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
| Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |